Levodopa and the progression of Parkinson's disease

MeSH terms

• Aged
• Cocaine / analogs & derivatives
• Cocaine / metabolism
• Corpus Striatum / diagnostic imaging
• Corpus Striatum / metabolism
• Corpus Striatum / physiopathology
• Disease Progression
• Dopamine / metabolism
• Dopamine Plasma Membrane Transport Proteins
• Dose-Response Relationship, Drug
• Double-Blind Method
• Female
• Humans
• Levodopa / administration & dosage*
• Levodopa / adverse effects*
• Male
• Membrane Glycoproteins / drug effects
• Membrane Glycoproteins / metabolism
• Membrane Transport Proteins / drug effects
• Membrane Transport Proteins / metabolism
• Middle Aged
• Nerve Degeneration / chemically induced*
• Nerve Degeneration / metabolism
• Nerve Degeneration / physiopathology
• Nerve Tissue Proteins / drug effects
• Nerve Tissue Proteins / metabolism
• Oxidative Stress / drug effects*
• Oxidative Stress / physiology
• Parkinson Disease / diagnostic imaging
• Parkinson Disease / drug therapy*
• Parkinson Disease / physiopathology
• Presynaptic Terminals / drug effects
• Presynaptic Terminals / metabolism
• Substantia Nigra / drug effects*
• Substantia Nigra / metabolism
• Substantia Nigra / physiopathology
• Tomography, Emission-Computed, Single-Photon
• Treatment Outcome